Anti-Cancer Drugs Often Fail to Meet Expectations | Mirage News

For over a decade, a class of drugs called BET inhibitors has been tested in cancer trials with high expectations. The biology looked promising. Many cancers depend on oncogenes that “Bromo- and Extra-Terminal domain” (BET) proteins help activate, so blocking BET proteins should slow tumor growth. In the lab, it often did. In patients, results
Source

0 Comments

Leave a reply

©2026 Game Changers ®

Terms and Conditions | Disclaimer

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Welcome

Install
×
PWA Add to Home Icon

Install this Game Changers on your iPhone PWA Add to Home Banner and then Add to Home Screen

×
x

Add Game Changers to your Homescreen by tap on share icon.

or

Log in with your credentials

or    

Forgot your details?

or

Create Account

Enable Notifications OK No thanks